Biotech News

Roche presents new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026

Roche Holdings AG (RHHBY)Roche Holdings AGCompany update

Basel, 10 November 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it will present new data across its pharmaceuticals and diagnostics portfolios at the 19 th Clinical Trials on Alzheimer’s Disease (CTAD) Congress, taking place in Boston, MA, from 16–19 November 2026. Across 16 accepted abstracts, including two scientific symposia and two oral presentations, Roche will highlight its differentiated approach to neurodegeneration: uniting high-accuracy diagnostic testing with targeted investigational therapeutics to address the disease across its continuum.

Related news

RHHBYRoche Holdings AG2026-10-21 12:00 EST

Roche presents new pivotal trial data across broad neuroimmunology portfolio at MSToronto2026

RHHBYRoche Holdings AG2026-10-19 05:00 EST

Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio

BMYBMYBristol-Myers Squibb Company2026-11-18 14:10 EST

Bristol Myers Squibb Presents First Clinical Data from Two Phase 3 Studies in the ADEPT Program Evaluating KarXT for Psychosis Associated with Alzheimer’s Disease

ARWRArrowhead Pharmaceuticals2026-11-07 21:15 EST

Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates

ZNTLZentalis2026-11-09 21:05 EST

Zentalis Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Updates

ARWRArrowhead Pharmaceuticals2026-11-04 12:30 EST

Arrowhead Pharmaceuticals Refinances Existing Credit Facility, Lowering Borrowing Costs and Extending Maturity

JNJJohnson & Johnson2026-10-19 12:23 EST

Johnson & Johnson announces new TREMFYA® (guselkumab) data showing durable 3-year outcomes in moderate to severe Crohn’s disease and expanding evidence in perianal fistula

BCRXBioCryst Pharmaceuticals2026-11-13 12:00 EST

BioCryst Presents New Real-World Evidence Showing Reduced Angioedema-Related Medical Visits After Switching to ORLADEYO® (berotralstat) at ACAAI 2026 Annual Scientific Meeting

NTLAIntellia2026-11-12 15:00 EST

Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026

DGXQuest Diagnostics2026-11-10 21:06 EST

Quest Diagnostics Declares Quarterly Cash Dividend

Roche Holdings AG

Integrated Pharmaceuticals and Diagnostics Company Roche is a global healthcare company that combines prescription medicines, diagnostic systems, and digital technologies within a single research and commercial organization. The group operates through Pharmaceuticals and Diagnostics divisions, with Genentech serving as its wholly owned...

Recent company news

Stock data

Close
59.00 USD
Market cap
—
Exchange
NASDAQ
Sector
Biopharma
Location
United States